₹66.25
+2.68 (+4.22%)
As of 15 Sept 2026, Brooks Laboratories Ltd share price is ₹66.25. The stock opened at ₹66.25 and had closed at ₹63.57 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹36.90 and a high of ₹162.80. In terms of performance, Brooks Laboratories Ltd share price has increased by 17.82% over the past six months and has decreased by 57.52% over the last year.
BROOKS Stock Price Chart
Brooks Laboratories Ltd Overview
Market cap₹195 Crs
Volume6,842
Prev. Close₹63.57
Year range₹36.90 - ₹162.80
ISININE650L01011
About BROOKS
Brooks Laboratories is engaged in pharmaceutical activities
Brooks Laboratories Ltd Historical Performance
1 Month Return10.42%
6 Month Return7.81%
3 Year Return-39.73%
3 Month Return1.53%
1 Year Return-56.60%
5 Year Return-55.55%
Brooks Laboratories Ltd Fundamentals
ROCE(TTM)5.11%
P/E Ratio (TTM)42.74
P/B Ratio1.61
Debt to Equity0.07
ROE4.80%
EPS (TTM)1.55
Dividend Yield0.00%
Book Value41.02
Profit Margin5.49%
Operating Margin5.04%
Brooks Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 86.91 | 83.44 | 80.41 | 55.66 | 77.92 |
| EBITDA | 8.24 | 5.86 | 4.16 | -5.69 | 2.83 |
| Net Profit | 5.81 | 3.05 | 1.53 | -8.18 | 0.67 |
| EPS | 1.97 | 1.14 | 0.58 | -3.32 | 0.27 |
Brooks Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 62.81 |
| Resistance 1 (R1) | 64.92 |
| Pivot Point | 64.15 |
BROOKS Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Durga Sankar Maity | Independent Director |
| Mr. Bhushan Singh Rana | E D & Wholetime Directorector |
| Jitendra Pratap Singh | E D & Wholetime Directorector |
Brooks Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,840.00-1.13% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,322.00-1.23% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,965.50+0.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Brooks Laboratories Ltd today is ₹66.25 on NSE and ₹66.25 on BSE.
- The 52-week high of Brooks Laboratories Ltd is ₹162.80, while the 52-week low is ₹36.90.
- The current market capitalisation of Brooks Laboratories Ltd is approximately ₹195 crore.
- The P/E (Price-to-Earnings) ratio of Brooks Laboratories Ltd is 8.59. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Brooks Laboratories Ltd is 1.60. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Brooks Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BROOKS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Brooks Laboratories Ltd has delivered a return of approximately -39.73%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Brooks Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 52.62% promoters, -9.90% FIIs, 10.38% DIIs, and 30.73% public shareholders.

